Who is sponsoring NCT03774940?

NCT03774940 is sponsored by TC Erciyes University.

What drugs are being tested in NCT03774940?

Interventions in NCT03774940: peripheric blood count.

What condition does NCT03774940 study?

NCT03774940 studies Urinary Tract Infection Bacterial, Nephrolithiasis.

Is NCT03774940 still recruiting?

NCT03774940 is currently completed. Last updated 13 December 2018.

Last reviewed 2018-12-13 · How we verify

NCT03774940

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Blood Parameters as a Predictor of Fever After Percutaneous Nephrolithotomy

Completed NA Last updated 13 December 2018

What this trial tests

NA trial testing peripheric blood count in Urinary Tract Infection Bacterial in 519 participants. Completed in 31 January 2014.

Timeline

1 January 2005

Primary endpoint
1 December 2013

31 January 2014

Quick facts

Lead sponsor	TC Erciyes University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	519
Start date	1 January 2005
Primary completion	1 December 2013
Estimated completion	31 January 2014
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

peripheric blood count

Conditions studied

Urinary Tract Infection Bacterial — all drugs for Urinary Tract Infection Bacterial →
Nephrolithiasis — all drugs for Nephrolithiasis →

Sponsor

TC Erciyes University

Who can join

18 and older, any sex, with Urinary Tract Infection Bacterial or Nephrolithiasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the relationship between neutrophil count, lymphocyte count, neutrophil-to-lymphocyte count ratio (NLR), and postoperative fever in patients undergoing percutaneous nephrolithotomy (PNL).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Urinary Tract Infection Bacterial

Currently open trials in the same condition.

NCT04291768 — Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia · Phase 4 · recruiting

Other TC Erciyes University trials

Trials by the same sponsor.

NCT07007858 — Effects of High-Velocity Passive Stretch on Spasticity, Function, and Muscle Structure in Spastic CP Children · NA · enrolling by invitation
NCT07529964 — MMP-2/3 and Periapical Healing Outcomes · not yet recruiting
NCT07526831 — Comparison of the Analgesic Efficacy of Adductor Canal Block and Combined Adductor Canal Block Plus IPACK Block in Knee · recruiting
NCT07371806 — EFFETCS OF MİNDFULNESS-BASED STRESS REDUCTION İN WOMEN WİTH CORONARY ARTERY DİSEASE · NA · not yet recruiting
NCT07499947 — Predicting Spinal Hypotension in Cesarean Section · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03774940 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by TC Erciyes University
Last refreshed: 13 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03774940.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing